Tag: DSM Group

DSM Group is a Russia-wide сompany that regularly monitors all pharmaceutical sectors, including import, distribution, pharmaceuticals retail sales, hospital procurement and state procurement under the State Reimbursement Program. Moreover, the сompany monitors sales of non-medicinal products, including skin care products and parapharmaceuticals (biologically active additives, diagnostic devices, personal care products, and health care products, etc.)

DSM and Panaceutics Announce Partnership to Boost Health and Wellness

DSM Sinochem Pharmaceuticals
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and digital health provider Panaceutics are joining forces to bring affordable personalized nutrition products ...

Russia Pharma Market Grew by 2.6%

The volume of the Russian pharmaceutical market in 2018 increased by 2.6% reaching 1.68 trillion rubles, follows from the annual report of DSM Group, cited by RIA Novosti. In real terms, drug sales in...

Russian pharmaceutical market: stability in unstable environment

According to DSM Group, in 2017, the Russian market was worth 1629 billion rubles, which 8% higher than in 2016. For the first time in three years, the market grew in dollar- and euro-denominated terms.

Nurofen, Kagocel and Detralex became top best-selling pharma products in Russia

Nurofen, an analgesic and antipyretic drug produced by Reckitt Benckiser Group , according to DSM Group, an analytical firm monitoring the pharmaceutical market, is the top selling medicine of 2017.

Russian drugs displace imports from the market

The first shifts in import substitution and expansion of innovative pharmaceutical production facilities occurred under Pharma - 2020, a state program which started as early as in 2011.

Bayer, Novartis and Teva topped February sales rankings in Russia

According to DSM Group, in February 2018, the commercial market of medicinal products amounted to 80.6 billion rubles (in retail prices). Compared to January 2018, the market volume increased by 4.0%.

Russian pharmacy market increased by 6.5% in ruble terms in 2017

In 2017, 5065.8 million packages of drugs worth 940.7 billion rubles (in retail prices) were sold through the pharmacies in Russia. This is 6.5% higher than in 2016 in value terms and 3.5% higher in physical terms.

Russian pharmaceutical market grew 7.5% in December 2017

In December 2017, the Russian commercial market of medicinal products was worth 69.3 billion rubles. Compared to November 2017, the market volume grew by 7.5%. On a year-over-year basis, the sales increased by 2.4%.

Russian pharmaceutical market expands by 13.3% in September 2017

According to DSM Group, in September 2017, the volume of commercial market for medicinal products was 59.6 billion rubles

Percentage of Russian-made drugs in healthcare procurement reached 72.4% in Q1

According to the hospital audit of Russian pharmaceutical market conducted by DSM Group, 203.9 million packages of medicinal products worth 45.9 billion rubles were purchased for healthcare facilities in Q1 2017

58% of medicines sold in Russia in April were produced domestically

According to the analytical report of DSM Group, in April 2017, the commercial market of medicinal products amounted to 53.9 billion rubles

Russian pharmaceutical market grew by 7% in 2016

According to the analytical report of DSM Group for 2016, the volume of the Russian pharmaceutical market reached 1344 billion rubles in 2016

The share of analgesics in packages on the Russian market is about 9%

According to the Russian pharmaceutical market audit by DSM Group, the analgesics occupy about 3% of the drug market in value terms, but the share in packages is much higher: about 9%. The main cha...